BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12449499)

  • 1. Bayesian analysis of population PK/PD models: general concepts and software.
    Lunn DJ; Best N; Thomas A; Wakefield J; Spiegelhalter D
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):271-307. PubMed ID: 12449499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
    Dodds MG; Vicini P
    Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach for PK/PD modeling with PD data below limit of quantification.
    Zhou H; Hartford A; Tsai K
    J Biopharm Stat; 2012; 22(6):1220-43. PubMed ID: 23075019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian hierarchical models for multi-level repeated ordinal data using WinBUGS.
    Qiu Z; Song PX; Tan M
    J Biopharm Stat; 2002 May; 12(2):121-35. PubMed ID: 12413235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population forecasts for Bangladesh, using a Bayesian methodology.
    Mahsin M; Hossain SS
    J Health Popul Nutr; 2012 Dec; 30(4):456-63. PubMed ID: 23304912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated covariate selection and Bayesian model averaging in population PK/PD models.
    Lunn DJ
    J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):85-100. PubMed ID: 17990086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.
    Yang S; Roger J
    Pharm Stat; 2010; 9(4):313-30. PubMed ID: 20043295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian regression in SAS software.
    Sullivan SG; Greenland S
    Int J Epidemiol; 2013 Feb; 42(1):308-17. PubMed ID: 23230299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast Bayesian whole-brain fMRI analysis with spatial 3D priors.
    Sidén P; Eklund A; Bolin D; Villani M
    Neuroimage; 2017 Feb; 146():211-225. PubMed ID: 27876654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHAISTOS: a framework for Markov chain Monte Carlo simulation and inference of protein structure.
    Boomsma W; Frellsen J; Harder T; Bottaro S; Johansson KE; Tian P; Stovgaard K; Andreetta C; Olsson S; Valentin JB; Antonov LD; Christensen AS; Borg M; Jensen JH; Lindorff-Larsen K; Ferkinghoff-Borg J; Hamelryck T
    J Comput Chem; 2013 Jul; 34(19):1697-705. PubMed ID: 23619610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7.
    Rambaut A; Drummond AJ; Xie D; Baele G; Suchard MA
    Syst Biol; 2018 Sep; 67(5):901-904. PubMed ID: 29718447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex Bayesian Modeling Workflows Encoding and Execution Made Easy With a Novel WinBUGS Plugin of the Drug Disease Model Resources Interoperability Framework.
    Larizza C; Borella E; Pasotti L; Tartaglione P; Smith M; Moodie S; Magni P
    CPT Pharmacometrics Syst Pharmacol; 2018 May; 7(5):298-308. PubMed ID: 29575824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCM: toolkit for Bayesian analysis of Computational Models using samplers.
    Thijssen B; Dijkstra TM; Heskes T; Wessels LF
    BMC Syst Biol; 2016 Oct; 10(1):100. PubMed ID: 27769238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Bayesian and maximum-likelihood inference of population genetic parameters.
    Beerli P
    Bioinformatics; 2006 Feb; 22(3):341-5. PubMed ID: 16317072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian inference.
    Bois FY
    Methods Mol Biol; 2013; 930():597-636. PubMed ID: 23086859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and spatio-temporal models with R-INLA.
    Blangiardo M; Cameletti M; Baio G; Rue H
    Spat Spatiotemporal Epidemiol; 2013 Dec; 7():39-55. PubMed ID: 24377114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critique of Computer Simulation Software's Used in Pharmacokinetics and Pharmacodynamics Analysis.
    Dave V; Yadav RB; Yadav S; Sharma S; Sahu RK; Ajayi AF
    Curr Clin Pharmacol; 2018; 13(4):216-235. PubMed ID: 30360723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.